Literature DB >> 26356486

Hypoxia Potentiates LPS-Mediated Cytotoxicity of BV2 Microglial Cells In Vitro by Synergistic Effects on Glial Cytokine and Nitric Oxide System.

Daniel Frey1, Susan Jung1, Florian Brackmann1, Mandy Richter-Kraus1, Regina Trollmann1.   

Abstract

BACKGROUND: Microglial activation due to a variety of stimuli induces secretion of neurotoxic substances including inflammatory cytokines and nitric oxide (NO). Clinical studies indicate a cross-link between inflammatory and hypoxia-regulated pathways suggesting that bacterial infections markedly sensitize the immature brain to hypoxic injury.
METHODS: The impact of inflammation and hypoxia on interleukin (IL)-1β, IL-6, tumor necrosis factor α (TNF-α), and NO secretion and microglia-induced cytotoxicity was investigated exposing BV2 cells to lipopolysaccharides (LPS) and hypoxia (1% O2). Cytotoxicity, NO, and cytokine release was quantified by MTS and Griess assays and by enzyme-linked immunosorbent assays, respectively.
RESULTS: LPS exposure of BV2 cells induced a significant, persistent production of NO, IL-1β, IL-6, and TNF-α. Even after LPS removal, ongoing NO and cytokine secretion was observed. Hypoxia mediated exclusively a significant, short-term IL-1β increase, but enhanced LPS-induced cytokine and NO secretion significantly. In addition, LPS-induced supernatants exhibited a stronger cytotoxic effect in glial and neuronal cells than LPS exposition (p < 0.001). Hypoxia potentiated LPS-induced cytotoxicity.
CONCLUSION: Present data prove that LPS-induced soluble factors rather than LPS exposure mediate microglial toxicity under conditions of hypoxia in vitro. Apart from potential protective effects of the hypoxia-inducible transcription factor (HIF)-1α system, activation of proinflammatory pathways may markedly sensitize microglial cells to promote hypoxia-induced injuries of the developing brain. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26356486     DOI: 10.1055/s-0035-1562924

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  6 in total

1.  Metabolic Enhancer Piracetam Attenuates the Translocation of Mitochondrion-Specific Proteins of Caspase-Independent Pathway, Poly [ADP-Ribose] Polymerase 1 Up-regulation and Oxidative DNA Fragmentation.

Authors:  Dinesh Kumar Verma; Sonam Gupta; Joyshree Biswas; Neeraj Joshi; K Sivarama Raju; Mu Wahajuddin; Sarika Singh
Journal:  Neurotox Res       Date:  2018-03-12       Impact factor: 3.911

2.  Acute induction of anomalous and amyloidogenic blood clotting by molecular amplification of highly substoichiometric levels of bacterial lipopolysaccharide.

Authors:  Etheresia Pretorius; Sthembile Mbotwe; Janette Bester; Christopher J Robinson; Douglas B Kell
Journal:  J R Soc Interface       Date:  2016-09       Impact factor: 4.118

3.  Prostaglandin I2 is responsible for ameliorating prostaglandin E2 stress in stimulating the expression of tumor necrosis factor α in a β-amyloid protein -dependent mechanism.

Authors:  Shao-Qin Zheng; Zi-Yi Gong; Chen-Di Lu; Pu Wang
Journal:  Oncotarget       Date:  2017-06-13

4.  Pleiotrophin regulates microglia-mediated neuroinflammation.

Authors:  Rosalía Fernández-Calle; Marta Vicente-Rodríguez; Esther Gramage; Jimena Pita; Carmen Pérez-García; Marcel Ferrer-Alcón; María Uribarri; María P Ramos; Gonzalo Herradón
Journal:  J Neuroinflammation       Date:  2017-03-04       Impact factor: 8.322

Review 5.  Neuroinflammation in Sepsis: Molecular Pathways of Microglia Activation.

Authors:  Carolina Araújo Moraes; Camila Zaverucha-do-Valle; Renaud Fleurance; Tarek Sharshar; Fernando Augusto Bozza; Joana d'Avila
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-01

6.  Redox DAPK1 destabilizes Pellino1 to govern inflammation-coupling tubular damage during septic AKI.

Authors:  Bang-Chuan Hu; Guo-Hua Wu; Zi-Qiang Shao; Yang Zheng; Jin-Quan Liu; Run Zhang; Jun Hong; Xiang-Hong Yang; Ren-Hua Sun; Shi-Jing Mo
Journal:  Theranostics       Date:  2020-09-15       Impact factor: 11.556

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.